🇨🇦 intravenous sufentanil and dexmedetomidine in Canada

intravenous sufentanil and dexmedetomidine (intravenous sufentanil and dexmedetomidine) regulatory status in Canada.

Marketing authorisation

intravenous sufentanil and dexmedetomidine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is intravenous sufentanil and dexmedetomidine approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for intravenous sufentanil and dexmedetomidine in Canada?

Jun Wang is the originator. The local marketing authorisation holder may differ — check the official source linked above.